Jamie Evan Craig

Title: Jamie Evan Craig: Innovator in Glaucoma Risk Assessment

Introduction

Jamie Evan Craig is a notable inventor based in Walkerville, Australia. She has made significant contributions to the field of ophthalmology, particularly in the assessment of glaucoma risk. Her innovative approach combines genetic analysis with clinical assessments to provide a comprehensive risk evaluation for individuals.

Latest Patents

Jamie Evan Craig holds a patent for "Methods and systems for assessing the risk of glaucoma." This patent outlines a method for determining a risk score for primary open-angle glaucoma based on the genetic content of a subject at various selected genetic loci or markers. The method assesses the risk by considering genetic associations with glaucoma, increased intraocular pressure, and other relevant traits. This innovative approach aims to enhance early detection and management of glaucoma, potentially improving patient outcomes.

Career Highlights

Throughout her career, Jamie has worked with esteemed institutions such as the Trustees of Flinders University and the Queensland Institute of Medical Research. Her work has focused on integrating genetic research with clinical practices to advance the understanding and treatment of glaucoma.

Collaborations

Jamie has collaborated with notable colleagues, including Stuart MacGregor and Alex William Hewitt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of glaucoma research.

Conclusion

Jamie Evan Craig's contributions to glaucoma risk assessment through her patented methods exemplify the intersection of genetics and clinical practice. Her work not only enhances our understanding of glaucoma but also paves the way for improved patient care and outcomes.